[ Amphora Medical raises $35.5M in Series B ]

Amphora Medical has raised $35.5 million in Series B funding.

Founded in 2011,  Amphora Medical is a medical device manufacturer that designs and develops cystoscopic technology for the treatment of overactive bladder syndrome.

The company  will use the proceeds from this financing to fund the U.S. pivotal study for its Selective Bladder Denervation System in women with OAB.

Funding  Series B
Founded  2011
Country  USA
City  Minneapolis, Minnesota
Founder / CEO  Danny Sachs
Deal Size  $35.5M
Investors   F-Prime Capital Partners
 Baird Capital
 HBM Healthcare Investments AG
 Boston Scientific
 Longitude Capital
Previous Investors  Baird Capital